Carmen Chak-Lui WONG

• Member, Hong Kong Young Academy of Sciences
• Professor, Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong
• Principal Investigator, State Key Laboratory of Liver Research, The University of Hong Kong
• Assistant Dean (Core Platforms & Advancement ), Li Ka Shing Faculty of Medicine, The University of Hong Kong

Dr. Carmen Chak-Lui Wong obtained her PhD degree in HKU and completed her post-doctoral training at Johns Hopkins University. She is the recipient of the NSFC Distinguished Young Scholars Fund, RGC Research Fellowship, Croucher Innovation Award, Hong Kong Young Scientist Award, the Rosie Young 90 Medal for Outstanding Young Woman Scholar, HKU Outstanding Young Researcher Award (OYRA), HKU Outstanding Research Student Supervisor Award (ORSSA), and Li Ka Shing Prize. Her research team is devoted to unraveling the complex mechanisms that drive metabolic reprogramming and immune evasion in liver cancer. Her team employs precision mouse models to gain a deeper understanding of personalized medicine for liver cancer. Her work was published in Gastroenterology, Gut, Journal of Hepatology, Hepatology, Nature Communications, Journal of Clinical Investigation, PNAS, Science Advances. She is the ESI top 1% most cited scholar in 2023-2025. She currently serves as the co-editor-in-chief of Hepatology Communications (AASLD) and the editorial board member of Hepatology (AASLD) and CMGH. She is also the council member of the governing board of the International Liver Cancer Association (ILCA).